Close Menu

Ciphergen this week said that Daniel Caserza, the company's interim chief financial officer, will resign effective from the company on June 2. Gail Page, president and CEO, will take his place until Ciphergen hires a replacement, the company said.

Ciphergen also said it has retained Financial Leadership Group to help it prepare its financial statements until it hires a permanent CFO.

Casera took over from Matthew Hogan, who abruptly resigned in March. Caserza joined Ciphergen in 1999. He became a vice president in April 2005.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.